The Securities and Exchange Commission says that a New York high-frequency trading firm committed fraud. But it's letting the company pay a million dollars to put the matter to rest without admitting or denying anything.
Want daily updates on important issues? Subscribe to
American drugmaker AbbVie is dropping a planned merger with the Irish company that makes Adderall, saying that new Treasury Department rules meant to crack down on deals done solely for tax purposes had nixed the plan.